The FDA’s Center for Drug Evaluation and Research (CDER) posted 11 Untitled Letters to pharmaceutical companies recently that were part of the agency’s Sept. 9 enforcement push. As with the letters posted in September, the new batch were signed by CDER Director Dr. George Tidmarsh. All the letters dealt with material for health care providers with seven of the letters concerne... Read More